Bromide

Bromide

SCHEMBL4634669

COc1ccc(N2C(=O)c3cccc4c(N=Cc5cc[n+](CCO)cc5)ccc(c34)C2=O)cc1OC.[Br-]

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.40
MEN1 O00255 4/20 0.40
CHAT P28329 1/20 0.40
NR1H3 Q13133 2/20 0.40
ALDH1A1 P00352 5/20 0.39
MAPT P10636 3/20 0.39
HTT P42858 3/20 0.39
KDM4E B2RXH2 3/20 0.39
LMNA P02545 3/20 0.39
POLB P06746 1/20 0.39
PABPC1 P11940 1/20 0.39
XBP1 P17861 1/20 0.39
NFKB1 P19838 1/20 0.39
SMARCA2 P51531 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
USP2 O75604 3/20 0.38
NR1H2 P55055 1/20 0.38
PRMT1 Q99873 1/20 0.37
HPGD P15428 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL4634200 1.00 KMT2A (0.40) KMT2AMEN1CHATNR1H3ALDH1A1
SCHEMBL4633403 0.99 KMT2A (0.41) KMT2AMEN1CHATNR1H3ALDH1A1
SCHEMBL4634206 0.99 KMT2A (0.41) KMT2AMEN1CHATNR1H3ALDH1A1
Bromide SCHEMBL4535340 0.85 KMT2A (0.42) KMT2AMEN1ALDH1A1MAPTHTT
Bromide SCHEMBL4535352 0.85 KMT2A (0.42) KMT2AMEN1ALDH1A1MAPTHTT
Bromide SCHEMBL4534732 0.82 MEN1 (0.41) KMT2AMEN1CHATALDH1A1MAPT
Bromide SCHEMBL4532718 0.82 MEN1 (0.41) KMT2AMEN1CHATALDH1A1MAPT
Bromide SCHEMBL3890946 0.76 MEN1 (0.39) KMT2AMEN1CHATALDH1A1MAPT
Bromide SCHEMBL3890949 0.76 MEN1 (0.39) KMT2AMEN1CHATALDH1A1MAPT
SCHEMBL5711637 0.75 MEN1 (0.40) KMT2AMEN1CHATALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1729723-B1 NEUTRAL AND CATIONIC NAPHTHALENE DERIVATIVES AND DYES CONTAINING SAID COMPOUNDS FOR DYEING KERATIN FIBERS WELLA AG (DE) 2008-06-04 EP claimed
US-20070151046-A1 Neutral and cationic naphthalene and colorants for keratin fibers containing these compounds Wella GmbH (DE) 2007-07-05 US claimed
EP-1729723-A1 NEUTRAL AND CATIONIC NAPHTHALENE DERIVATIVES AND DYES CONTAINING SAID COMPOUNDS FOR DYEING KERATIN FIBERS Wella Aktiengesellschaft (DE) 2006-12-13 EP disclosed
WO-2005075574-A1 NEUTRAL AND CATIONIC NAPHTHALENE DERIVATIVES AND DYES CONTAINING SAID COMPOUNDS FOR DYEING KERATIN FIBERS WELLA AKTIENGESELLSCHAFT (DE) 2005-08-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070151046-A1 Neutral and cationic naphthalene and colorants for keratin fibers containing these compounds KRT18, NUP205, KPNA1 KMT2A 2261/4885MEN1 2181/4885CHAT 999/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.